Short sleep duration is associated with worse quality of life in Parkinson's disease: A multicenter cross-sectional study
Jingxue Liang,Yuhui Wang,Xiaobo Zhu,Xiaojun Hou,Guojun Luo,Wen Li,Jun Liu,Wenzhao Wang,Jianmin Wang,Jialan Sun,Feng Yu,Weiwen Wu,Weidong Pan,Zhenguo Liu,Yu Zhang
DOI: https://doi.org/10.1016/j.sleep.2024.01.002
IF: 4.842
2024-01-07
Sleep Medicine
Abstract:Objective To characterize sleep duration and investigate its association with quality of life among Parkinson's Disease (PD) patients. Methods In this multicenter cross-sectional study, 970 PD patients were divided into five groups based on self-reported sleep duration: <5, ≥5 to <6, ≥6 to 8 h. The quality of life was evaluated using the 39-Item Parkinson's Disease Questionnaire (PDQ-39). Multivariable linear regression analysis, subgroup analysis, and mediation analysis were conducted to examine the association between sleep duration and quality of life. Results In multivariable linear regression model, patients with sleep duration (<5 h) had significantly higher PDQ-39 scores (β = 8.132, 95 % CI: 3.99 to 12.266), especially in mobility, activities of daily living, emotional well-being, stigma, social support, cognition, communication, and bodily discomfort (p < 0.05). The association between sleep duration (<5 h) and worse quality of life was more pronounced in patients with higher HY stage, longer disease duration, and sleep disorders. Moreover, a significant indirect effect of sleep duration (<5 h) on quality of life was observed, with UPDRS I, UPDRS II, and UPDRS IV scores acting as mediators. Conclusions Short sleep duration (<5 h) is associated with worse quality of life among PD patients. This association was stronger among patients with advanced PD and sleep disorders, while non-motor symptoms and motor complications were identified as significant mediators in this association. These findings highlight the significance of adequate sleep duration and suitable interventions for sleep may help improve quality of life.
clinical neurology